Grants - LA/ER Transdermal Drug Delivery

Advancing Sustained/Extended Release for HIV Prevention (A-SER)

Grant Source: 
NIH/NIAID

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate the development of new and innovative sustained/extended release (SER) drug delivery systems (DDS) that can achieve extended durations (months to years) and provide systemic protection from all routes of HIV infection/transmission in at-risk individuals.

Application Deadline: December 4, 2019, by 5:00 PM local time of applicant organization

Health Topics: 
HIV
LA/ER Implantable Therapy
LA/ER Injectable Therapy
LA/ER Transdermal Drug Delivery